Allergan (AGN) Downgraded By Argus Research; Sabra Health Care REIT (SBRA) Has 1.81 Sentiment

December 7, 2017 - By Henry Gaston

Among 25 analysts covering Allergan Inc. (NYSE:AGN), 17 have Buy rating, 0 Sell and 8 Hold. Therefore 68% are positive. Allergan Inc. has $400 highest and $193.0 lowest target. $269.86’s average target is 64.62% above currents $163.93 stock price. Allergan Inc. had 96 analyst reports since July 29, 2015 according to SRatingsIntel. As per Thursday, November 3, the company rating was maintained by Morgan Stanley. The rating was maintained by Mizuho on Tuesday, November 1 with “Buy”. The firm has “Equal-Weight” rating by Morgan Stanley given on Thursday, November 2. The rating was maintained by Cantor Fitzgerald with “Hold” on Tuesday, August 29. The firm earned “Buy” rating on Tuesday, October 17 by Credit Suisse. As per Friday, May 13, the company rating was maintained by Mizuho. The rating was maintained by Piper Jaffray on Thursday, August 3 with “Hold”. The firm has “Buy” rating given on Tuesday, August 9 by Deutsche Bank. Mizuho maintained the shares of AGN in report on Wednesday, November 1 with “Hold” rating. The firm has “Hold” rating by Piper Jaffray given on Friday, July 14.

Sabra Health Care REIT, Inc. operates as a real estate investment trust in the United States. The company has market cap of $3.42 billion. The company, through its subsidiaries, owns and invests in real estate properties for the healthcare industry. It has a 22.02 P/E ratio. The Company’s property portfolio consists of 86 properties comprising 67 skilled nursing facilities; 10 combined skilled nursing, assisted living, and independent living facilities; 5 assisted living facilities; 2 mental health facilities; 1 independent living facility; and 1 continuing care retirement community.

The stock increased 1.81% or $0.34 during the last trading session, reaching $19.16. About 349,901 shares traded. Sabra Health Care REIT, Inc. (SBRA) has risen 23.68% since December 7, 2016 and is uptrending. It has outperformed by 6.98% the S&P500.

Leisure Capital Management holds 4.33% of its portfolio in Sabra Health Care REIT, Inc. for 201,705 shares. Forward Management Llc owns 1.20 million shares or 2.45% of their US portfolio. Moreover, Gilman Hill Asset Management Llc has 1.88% invested in the company for 180,707 shares. The New York-based Manikay Partners Llc has invested 1.72% in the stock. Copper Rock Capital Partners Llc, a Massachusetts-based fund reported 780,485 shares.

Analysts await Sabra Health Care REIT, Inc. (NASDAQ:SBRA) to report earnings on February, 28. They expect $0.67 EPS, up 8.06% or $0.05 from last year’s $0.62 per share. SBRA’s profit will be $119.42 million for 7.15 P/E if the $0.67 EPS becomes a reality. After $0.60 actual EPS reported by Sabra Health Care REIT, Inc. for the previous quarter, Wall Street now forecasts 11.67% EPS growth.

The stock decreased 2.42% or $4.07 during the last trading session, reaching $163.93. About 1.22M shares traded. Allergan plc (NYSE:AGN) has declined 3.42% since December 7, 2016 and is downtrending. It has underperformed by 20.12% the S&P500.

Investors sentiment decreased to 0.38 in Q2 2017. Its down 2.62, from 3 in 2017Q1. It fall, as 4 investors sold Allergan plc shares while 4 reduced holdings. 0 funds opened positions while 3 raised stakes. 57,100 shares or 18.39% less from 69,971 shares in 2017Q1 were reported. The California-based Dowling Yahnke Limited Liability Co has invested 0.05% in Allergan plc (NYSE:AGN). Grassi Mngmt invested 0.36% in Allergan plc (NYSE:AGN). Gemmer Asset Mgmt Ltd Liability stated it has 135 shares. Frontier Mngmt Company holds 0.71% or 29,992 shares. Connors Investor Services has 0.04% invested in Allergan plc (NYSE:AGN) for 1,000 shares. American & Mgmt owns 33 shares or 0% of their US portfolio. Cubic Asset Mgmt Ltd Company has invested 0.16% in Allergan plc (NYSE:AGN). Marshwinds Advisory reported 892 shares stake. Toth Advisory Corporation stated it has 958 shares or 0.06% of all its holdings. Mitchell Mcleod Pugh And Williams owns 3,975 shares. Bartlett And Ltd holds 21 shares. Eqis Cap Mgmt has invested 0.1% in Allergan plc (NYSE:AGN).

Analysts await Allergan plc (NYSE:AGN) to report earnings on February, 14. They expect $4.74 earnings per share, up 21.54% or $0.84 from last year’s $3.9 per share. AGN’s profit will be $1.58B for 8.65 P/E if the $4.74 EPS becomes a reality. After $4.15 actual earnings per share reported by Allergan plc for the previous quarter, Wall Street now forecasts 14.22% EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com